Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets
Aug 12, 2026 1:00 PM Eastern Daylight Time U.S. manufacturing agreement advances Cycle’s preparations to introduce CAVHANZA to patients with ...
Forma Life Sciences Launches U.S. Based Contract Development and Manufacturing Organization (CDMO) for Oral Solid Dosage Development and Commercial Manufacturing in Irvine, California
Mar 3, 2026 11:00 AM Eastern Standard Time IRVINE, Calif.--(BUSINESS WIRE)--Forma Life Sciences, Inc. today announced its launch as an ...
BioSelective Capital Investments Completes Acquisition of BioDuro’s Irvine, California Drug Product Development and Manufacturing Operations
Feb 4, 2026 10:00 AM Eastern Standard Time PARK CITY, Utah & IRVINE, Calif.--(BUSINESS WIRE)--BioSelective Capital Investments and Shayan Enterprises, ...